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Abstract
Background: The association of rs1044925 polymorphism in the acyl-CoA:cholesterol acyltransferase-1 (ACAT-1)
gene and serum lipid profiles is not well known in different ethnic groups. Bai Ku Yao is a special subgroup of the
Yao minority in China. The present study was carried out to clarify the association of rs1044925 polymorphism in
the ACAT-1 gene and several environmental factors with serum lipid levels in the Guangxi Bai Ku Yao and Han
populations.
Methods: A total of 626 subjects of Bai Ku Yao and 624 participants of Han Chinese were randomly selected from
our previous stratified randomized cluster samples. Genotyping of rs1044925 polymorphism in the ACAT-1 gene
was performed by polymerase chain reaction and restriction fragment length polymorphism combined with gel
electrophoresis, and then confirmed by direct sequencing.
Results: The levels of serum total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), apolipoprotein (Apo) AI
and ApoB were lower in Bai Ku Yao than in Han (P < 0.01 for all). The frequency of A and C alleles was 79.0% and 21.0%
in Bai Ku Yao, and 87.3% and 12.7% in Han (P < 0.001); respectively. The frequency of AA, AC and CC genotypes was
63.2%, 31.4% and 5.2% in Bai Ku Yao, and 75.6%, 23.2% and 1.1% in Han (P < 0.001); respectively. The levels of TC, LDL-C
and ApoB in Bai Ku Yao but not in Han were different between the AA and AC/CC genotypes in females but not in
males (P < 0.05 for all). The C allele carriers had lower serum TC, LDL-C and ApoB levels as compared with the C allele
noncarriers. The levels of TC, LDL-C and ApoB in Bai Ku Yao but not in Han were correlated with genotypes in females
but not in males (P < 0.05 for all). Serum lipid parameters were also correlated with sex, age, body mass index, alcohol
consumption, and blood pressure in both ethnic groups (P < 0.05-0.001).
Conclusions: These results suggest that the polymorphism of rs1044925 in the ACAT-1 gene is mainly associated
with female serum TC, LDL-C and ApoB levels in the Bai Ku Yao population. The C allele carriers had lower serum
TC, LDL-C and ApoB levels than the C allele noncarriers.
Introduction
Coronary artery disease (CAD) is a major health pro-
blem and the leading cause of death in many industria-
lized countries [1,2]. Dyslipidemia such as elevated
serum levels of total cholesterol (TC) [3], triglyceride
(TG) [4], low-density lipoprotein cholesterol (LDL-C)
[5], and apolipoprotein (Apo) B [6], or low levels of
high-density lipoprotein cholesterol (HDL-C) and
ApoAI [6-8] is one of the most important modifiable
risk factors for CAD in western [9,10] as well as in
Asian [11,12] populations. It has been well established
that dyslipidemia is a complex trait caused by multiple
environmental [13,14] and genetic factors [15-17] and
their interactions [18,19]. Family history and twin
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account for 40-60% of the interindividual variation in
plasma lipid phenotypes [20-22].
Cholesterol in the body is present in tissues and
plasma lipoproteins either as free cholesterol or choles-
teryl esters. The esterification of cholesterol in plasma
by lecithin: cholesterol acyltransferase (LCAT) plays an
important role in the intravascular maturation of lipo-
proteins, sepecially HDL. In contrast, intracellular cho-
lesteryl ester synthesis, catalyzed by acyl-CoA:cholesterol
acyltransferase (ACAT, E.C.2.3.1.26), also called sterol
o-acyltransferase (SOAT), serves to store cholesterol in
cytosolic droplets and also participates in the hepatic
secretion of lipoproteins containing ApoB [23-26].
ACAT has found to be present as two isoforms, ACAT-
1 and ACAT-2, with different intracellular localizations,
membrane topology in mammalian species, and meta-
bolic function for each enzyme [27-29]. ACAT-1 is ubi-
quitously expressed in various tissues and cells including
adrenal glands, kidney [30-32], and macrophages [33]
and is responsible for foam cell formation in macro-
phages, whereas ACAT-2 is expressed only in intestine
and liver [27,28,34] and is in charge of the cholesterol
absorption process in intestinal mucosal cells [35]. The
first ACAT-1 cDNA was cloned by Chang and collea-
gues [30] in 1993. ACAT-2 was cloned in 1998
[27,28,34]. The two genes have 47% overall nucleotide
identity [30,34] and encode specific ACAT proteins that
have 43% amino acid sequence identity and 63% similar-
ity. ACAT activity has been detected in a diverse range
of tissues and cell types [36] and is known to play an
important role in cell biology and in the pathogenesis of
important lipid-related diseases such as atherosclerosis
[36] and cholesterol gallstones [37]. For example, ACAT
has been shown to play a pivotal functional role in the
intestinal absorption of cholesterol, the hepatic secretion
of very low-density lipoprotein (VLDL), the biosynthesis
of steroid hormones, the production of cholesteryl esters
in macrophages (foam cells) in atheroma, and the secre-
tion of biliary cholesterol. From a biochemical and phy-
siological perspective, ACAT is one of the central
enzymes regulating plasma and biliary cholesterol con-
centrations. In several previous studies, two single
nucleotide polymorphisms (SNPs) of rs1044925 and
-77G > A in the ACAT-1 gene were associated with
modifications of serum lipid concentrations [38,39] and
with low cerebrospinal fluid levels of cholesterol [40],
but one SNP (R526G) in the ACAT-1 gene was not
associated with serum lipid parameters [39].
China is a vast and diverse country. There are 56 ethnic
groups. Han is the largest ethnic group and Yao is the
eleventh largest minority among the 55 minority groups
according to the population size. Bai Ku Yao (White-trouser
Yao), an isolated branch of the Yao minority, is named so
because all of men wear white knee-length knickerbockers.
The population size is about 30000. Because of isolation
from the other ethnic groups, the special customs and
cultures including their clothing, intra-ethnic marriages,
ballad, funeral, bronze drum, spinning top, dietary habits,
and corn wine and rum intakes are still completely
preserved to the present day. They are currently in a transi-
tional period from the matriarchal society to patriarchal
society. In several previous epidemiological studies, we
showed that several serum lipid phenotypes were lower in
Bai Ku Yao than in Han Chinese from the same region
[13,14]. This ethnic difference in serum lipid profiles is still
not well known. We hypothesized that some genetic factors
may be different between the two ethnic groups. Therefore,
the aim of the present study was to detect the association of
rs1044925 polymorphism in the ACAT-1 gene and several
environmental factors with serum lipid phenotypes in the
Guangxi Bai Ku Yao and Han populations.
Materials and methods
Study population
A total of 626 subjects of Bai Ku Yao who reside in Lihu
and Baxu villages in Nandan County, Guangxi Zhuang
Autonomous Region, People’s Republic of China were
randomly selected from our previous stratified rando-
mized cluster samples [13,14]. The ages of the subjects
ranged from 15 to 80 years, with an average age of 40.25
± 14.97 years. There were 305 males (48.72%) and 321
females (51.28%). All subjects were rural agricultural
workers. The subjects accounted for 2.09% of total Bai
Ku Yao population. During the same period, a total of
6 2 4p e o p l eo fH a nC h i n e s ew h or e s i d ei nt h es a m e
villages were also randomly selected from our previous
stratified randomized cluster samples [13,14]. The aver-
age age of the subjects was 40.71 ± 15.71 years (range 15
to 80). There were 304 men (48.72%) and 320 women
(51.28%). All of them were also rural agricultural work-
ers. All study subjects were essentially healthy and had
no evidence of any chronic illness, including hepatic,
renal, or thyroid. The participants with a history of heart
attack or myocardial infarction, stroke, congestive heart
failure, diabetes or fasting blood glucose ≥7.0 mmol/L
determined by glucose meter have been excluded. The
participants were not taking medications known to affect
serum lipid levels (lipid-lowering drugs such as statins or
fibrates, beta-blockers, diuretics, or hormones). The pre-
sent study was approved by the Ethics Committee of the
First Affiliated Hospital, Guangxi Medical University.
Informed consent was obtained from all subjects after
they received a full explanation of the study.
Epidemiological survey
The survey was carried out using internationally stan-
dardized methods, following a common protocol [41].
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lifestyle factors was collected with standardized question-
naires. The alcohol information included questions about
the number of liangs (about 50 g) of rice wine, corn wine,
rum, beer, or liquor consumed during the preceding 12
months. Alcohol consumption was categorized into
groups of grams of alcohol per day: <25 and ≥25. Smok-
ing status was categorized into groups of cigarettes per
day: <20 and ≥20. At the physical examination, several
anthropometric parameters, such as height, weight, and
waist circumference were measured. Sitting blood pres-
sure was measured three times with the use of a mercury
sphygmomanometer after the subjects had a 5-minute
rest, and the average of the three measurements was used
for the level of blood pressure. Systolic blood pressure
was determined by the first Korotkoff sound, and diasto-
lic blood pressure by the fifth Korotkoff sound. Body
weight, to the nearest 50 grams, was measured using a
portable balance scale. Subjects were weighed without
shoes and in a minimum of clothing. Height was mea-
sured, to the nearest 0.5 cm, using a portable steel mea-
suring device. From these two measurements body mass
index (BMI, kg/m
2) was calculated.
Biochemical analysis
A venous blood sample of 8 mL was obtained from all
subjects between 8 and 11 AM, after at least 12 hours
of fasting, from a forearm vein after venous occlusion
for few seconds in a sitting position. A part of the sam-
ple (3 mL) was collected into glass tubes and allowed to
clot at room temperature, and used to determine serum
lipid levels. Another part of the sample (5 mL) was
transferred to tubes with anticoagulate solution (4.80 g/L
citric acid, 14.70 g/L glucose, and 13.20 g/L tri-sodium
citrate) and used to extract DNA. Immediately following
clotting serum was separated by centrifugation for 15
minutes at 3000 rpm. The levels of TC, TG, HDL-C,
and LDL-C in samples were determined by enzymatic
methods with commercially available kits, Tcho-1, TG-
LH (RANDOX Laboratories Ltd., Ardmore, Diamond
Road, Crumlin Co. Antrim, United Kingdom, BT29
4QY), Cholestest N HDL, and Cholestest LDL (Daiichi
Pure Chemicals Co., Ltd., Tokyo, Japan); respectively.
Serum ApoAI and ApoB levels were detected by the
immunoturbidimetric immunoassay using a commercial
kit (RANDOX Laboratories Ltd.). All determinations
were performed with an autoanalyzer (Type 7170A; Hita-
chi Ltd., Tokyo, Japan) in the Clinical Science Experi-
ment Center of the First Affiliated Hospital, Guangxi
Medical University [13,14].
DNA amplification and genotyping
Genomic DNA was isolated from peripheral blood leuko-
cytes using the phenol-chloroform method [15-19]. The
extracted DNA was stored at 4°C until analysis. Genotyp-
ing of the polymorphism of rs1044925 was performed by
polymerase chain reaction and restriction fragment length
polymorphism (PCR-RFLP) [38,42]. PCR amplification
was performed using 5’-TATATTAAGGGGATCA-
GAAGT-3’ and 5’-CCACCTAAAAACATACTACC-3’
(Sangon, Shanghai, People’s Republic of China) as the for-
ward and reverse primer pairs; respectively. Each amplifi-
cation reaction was performed using 0.5 μgo fg e n o m i c
DNA in 25 μL of reaction mixture consisting of 0.2 μMo f
each primer, 200 μM of each deoxynucleotide triphoi-
sphate, 2.5 μL of 10 × PCR buffer (100 mM Tris-HCl, pH
8.3, 500 mM KCl, 20 mM MgCl2,1 %T r i t o n ) ,a n d1 . 2 5
units of Taq polymerase. After initial denaturizing at 95°C
for 5 min, the reaction mixture was subjected to 33 cycles
of 45 s denaturation at 95°C, 30 s annealing at 53°C and
extension 50 s at 72°C, followed by a final 10 min exten-
sion at 72°C. After electrophoresis on a 1.5% agarose gel
with 0.5 μg/mL ethidium bromide, the amplification pro-
ducts were visualized under ultraviolet light. Then 5 U of
RsaI restriction enzyme was added directly to the PCR
products (5 μL) and digested at 37°C overnight. After
restriction enzyme digestion of the amplified DNA, geno-
types were identified by electrophoresis on 1.5% agarose
gels and visualized with ethidium-bromide staining ultra-
violet illumination. The genotypes were scored by an
experienced reader blinded to the epidemiological data
and serum lipid levels. Six samples (AA, AC and CC geno-
types in two; respectively) detected by the PCR-RFLP were
also confirmed by direct sequencing. The PCR products
were purified by low melting point gel electrophoresis and
phenol extraction, and then the DNA sequences were ana-
lyzed in Shanghai Sangon Biological Engineering Technol-
ogy & Services Co., Ltd., People’sR e p u b l i co fC h i n a .
Diagnostic criteria
The normal values of serum TC, TG, HDL-C, LDL-C,
ApoAI, ApoB levels, and the ratio of ApoAI to ApoB in our
Clinical Science Experiment Center were 3.10-5.17, 0.56-
1.70, 0.91-1.81, 2.70-3.20 mmol/L, 1.00-1.78, 0.63-1.14 g/L,
and 1.00-2.50; respectively. The individuals with TC > 5.17
mmol/L and/or TG > 1.70 mmol/L were defined as hyperli-
pidemic [13,14]. Hypertension was diagnosed according to
the criteria of 1999 World Health Organization-Interna-
tional Society of Hypertension Guidelines for the manage-
ment of hypertension [43,44]. The diagnostic criteria of
overweight and obesity were according to the Cooperative
Meta-analysis Group of China Obesity Task Force. Normal
weight, overweight and obesity were defined as a BMI < 24,
24-28, and > 28 kg/m
2; respectively [45].
Statistical analyses
Epidemiological data were recorded on a pre-designed
form and managed with Excel software. All statistical
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SPSS 13.0 (SPSS Inc., Chicago, Illinois). Quantitative
variables were expressed as mean ± standard deviation
(serum TG levels were presented as medians and inter-
quartile ranges). Qualitative variables were expressed as
percentages. Allele frequency was determined via direct
counting, and the standard goodness-of-fit test was used
to test the Hardy-Weinberg equilibrium. Difference in
genotype distribution between the groups was obtained
using the chi-square test. The difference in general char-
acteristics between Bai Ku Yao and Han was tested by
the Student’su n p a i r e dt-test. The association of geno-
types and serum lipid parameters was tested by analysis
of covariance (ANCOVA). Se x ,a g e ,B M I ,b l o o dp r e s -
sure, alcohol consumption, cigarette smoking were
adjusted for the statistical analysis. In order to evaluate
the association of serum lipid levels with genotypes (AA
= 1, AC/CC = 2) and several environment factors, mul-
tiple linear regression analysis with stepwise modeling
was also performed in the combined population of Bai
Ku Yao and Han, Bai Ku Yao, Han, males and females;
respectively. A P value of less than 0.05 was considered
statistically significant.
Results
General characteristics and serum lipid levels
Table 1 gives the general characteristics and serum lipid
levels between the Bai Ku Yao and Han populations.
The levels of height, weight,B M I ,s y s t o l i cb l o o dp r e s -
s u r e ,p u l s ep r e s s u r e ,s e r u mT C ,H D L - C ,A p o A I ,A p o B
were lower in Bai Ku Yao than in Han Chinese (P <
0.05-0.001), whereas the percentage of subjects who
consumed alcohol was higher in Bai Ku Yao than in
Han (P < 0.001). There was no significant difference in
the levels of diastolic blood pressure, serum TG, LDL-C,
the ratio of ApoAI to ApoB, age structure, the percen-
tage of subjects who smoked cigarettes, or the ratio of
male to female between the two ethnic groups (P >0 . 0 5
for all).
Results of electrophoresis and genotyping
After the genomic DNA of the samples was amplified
by PCR and imaged by 1.5% agarose gel electrophoresis,
the purpose gene of 389 bp nucleotide sequences could
be found in all samples (Figure 1). The genotypes iden-
tified were named according to the presence or absence
of the enzyme restriction sites, when an A to C trans-
version at rs1044925 locus of the ACAT-1 gene. The
presence of the cutting site indicates the C allele, while
its absence indicates the A allele (cannot be cut). Thus,
the AA genotype is homozygote for the absence of the
site (band at 389 bp), AC genotype is heterozygote for
the absence and presence of the site (bands at 389-,
279- and 110-bp), and CC genotype is homozygote for
the presence of the site (bands at 279- and 110-bp;
Figure 2).
Genotypic and allelic frequencies
The genotypic and allelic frequencies of rs1044925 poly-
morphism in the ACAT-1 gene are shown in Table 2.
The frequency of A and C alleles was 79.0% and 21.0%
in Bai Ku Yao, and 87.3% and 12.7% in Han (P < 0.001);
respectively. The frequency of AA, AC and CC geno-
types was 63.2%, 31.4% and 5.2% in Bai Ku Yao, and
75.6%, 23.2% and 1.1% in Han (P < 0.001); respectively.
There was no significant difference in the genotypic and
allelic frequencies between the males and females in
both ethnic groups.
Results of sequencing
The results were shown as AA, AC and CC genotypes
by PCR-RFLP, the AA, AC and CC genotypes were also
confirmed by sequencing (Figure 3); respectively.
Table 1 The general characterisrics and serum lipid levels
between Bai Ku Yao and Han Chinese
Parameter Bai Ku Yao Han
Chinese
t (c
2) P
Number 626 624 - -
Male/female 305/321 304/320 0.000 0.999
Age (years) 40.25 ±
14.97
40.71 ±
15.71
-0.523 0.601
Height (cm) 152.69 ±
7.46
155.41 ±
8.23
-6.102 0.000
Weight (kg) 51.84 ± 7.17 54.51 ± 9.28 -5.703 0.000
Body mass index (kg/m
2) 22.20 ± 2.38 22.54 ± 3.22 -2.126 0.034
Systolic blood pressure
(mmHg)
119.30 ±
16.97
121.28 ±
16.74
-2.077 0.038
Diastolic blood pressure
(mmHg)
75.59 ± 9.53 76.21 ±
10.61
-1.087 0.277
Pulse pressure (mmHg) 43.71 ±
12.83
45.09 ±
11.65
-1.982 0.048
Cigarette smoking [n (%)]
Nonsmoker 429 (68.5) 448 (71.8)
< 20 cigarettes/day 90 (14.4) 70 (11.2)
≥ 20 cigarettes/day 107 (17.1) 106 (17.0) 2.913 0.233
Alcohol consumption [n (%)]
Nondrinker 334 (53.4) 392 (62.8)
< 25 g/day 189 (30.2) 160 (25.6)
≥ 25 g/day 103 (16.5) 72 (11.5) 12.532 0.002
Total cholesterol (mmol/L) 4.34 ± 0.87 4.74 ± 1.02 -7.419 0.000
Triglyceride (mmol/L) 1.00 (0.65) 1.01 (0.69) -0.982 0.326
HDL-C (mmol/L) 1.66 ± 0.41 1.89 ± 0.50 -8.790 0.000
LDL-C (mmol/L) 2.56 ± 0.72 2.63 ± 0.77 -1.539 0.124
Apolipoprotein (Apo) AI (g/L) 1.31 ± 0.32 1.42 ± 0.28 -6.478 0.000
ApoB (g/L) 0.85 ± 0.22 0.89 ± 0.22 -3.361 0.001
ApoAI/ApoB 1.66 ± 0.72 1.69 ± 0.58 -0.651 0.515
HDL-C, highdensity lipoprotein cholesterol; LDL-C, low-density lipoprotein
cholesterol. The value of TG was presented as median (interquartile range).
The difference between the two ethnic groups was determined by the
Wilcoxon-Mann-Whitney test.
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As shown in Table 3 the levels of TC, LDL-C and ApoB
in Bai Ku Yao but not in Han were significant differ-
ences between the AA and AC/CC genotypes in females
but not in males (P < 0.05 for all). The subjects with
AC/CC genotype had lower serum TC, LDL-C and
ApoB levels than the subjects with AA genotype. There
was no significant difference in serum lipid parameters
between the AA and AC/CC genotypes in both ethnic
groups (P > 0.05 for all).
Relative factors for serum lipid parameters
Multiple linear regression analysis showed that the gen-
otypes of rs1044925 polymorphism in the ACAT-1 gene
were not correlated with any serum lipid parameters in
the combined population of Bai Ku Yao and Han, in the
Bai Ku Yao or in the Han population (Table 4). When
multiple linear regression analysis was performed in the
males and females in both ethnic groups; respectively,
we found that the levels of TC, LDL-C and ApoB in Bai
Ku Yao but not in Han were correlated with genotypes
in females but not in males (P < 0.05 for all, Table 5).
Serum lipid parameters were also correlated with sex,
age, BMI, alcohol consumption, and blood pressure in
both ethnic groups (Table 4 and 5).
Discussion
We showed that the levels of serum TC, HDL-C, ApoAI
and ApoB were lower in Bai Ku Yao than in Han Chi-
nese. There was no significant difference in the serum
levels of TG, LDL-C and the ratio of ApoAI to ApoB
between the two ethnic groups. It is well known that
dyslipidemia is a multifactorial origin, including heredi-
tary and acquired risk factors. Bai Ku Yao is a special
a n di s o l a t e ds u b g r o u po ft h eY a om i n o r i t yi nC h i n a .
There are about 30000 people of total Bai Ku Yao popu-
lation who reside in two villages, Lihu and Baxu, Nan-
dan County. Their ancestors began their migration from
Hunan and Guizhou Province about Song Dynasty. Both
Lihu and Baxu villages are typical infertile mountain
area, usually it was called 30 percent soil with 70 per-
cent rock. Thus, their income mostly comes from plant-
ing corn and paddy. Strict intra-ethnic marriages have
been performed in this ethnic subgroup from time
immemorial. Therefore, we believe that some hereditary
characteristics and genotypes of lipid metabolism-related
genes in this population may be different from those in
Han Chinese.
In the present study, we showed that the frequency of
C allele of rs1044925 in the ACAT-1 gene was higher in
Bai Ku Yao (21.0%) than in Han Chinese (12.7%). The
frequency of AC and CC genotypes was also higher in
Bai Ku Yao than in Han. In a previous study in northern
Han Chinese population, Zhao et al. [42] reported that
there was no difference in the frequency of C allele
between normal controls (9.7%) and Alzheimer’s disease
patients (9.3%). In another recent study in Han Chinese
population, Li et al. [38] also found no significant differ-
ence in the frequency of C allele between normal con-
trols (13.7%) and endogenous hypertriglyceridemia
patients (15.3%). The allele frequency of the R526G
Figure 1 Electrophoresis of PCR products of the samples. Lane
M, 100 bp marker ladder; lanes 1-6, samples. The 389 bp bands are
the target genes.
Figure 2 Genotyping of rs1044925 polymorphism in the ACAT-
1 gene. Lane M, 100 bp marker ladder; lanes 1-3, AA genotype (389
bp); lanes 4 and 5, AC genotype (389-, 279- and 110-bp); and lanes
6 and 7, CC genotype (279- and 110-bp).
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Table 2 The genotypic and allelic frequencies of rs1044925 polymorphism in the ACAT-1 gene between Bai Ku Yao
and Han Chinese [n (%)]
Genotype Allele
Group n AA AC CC A C
Bai Ku Yao 626 396 (63.2) 197 (31.4) 33 (5.2) 989 (79.0) 263 (21.0)
Han Chinese 624 472 (75.6) 145 (23.2) 7 (1.1) 1089 (87.3) 159 (12.7)
c
2 - 31.458 30.436
P - 0.000 0.000
Bai Ku Yao
Male 305 191 (62.6) 96 (31.5) 18 (5.9) 478 (78.4) 132 (21.6)
Female 321 205 (63.9) 101 (31.5) 15 (4.7) 511 (79.6) 131 (20.4)
c
2 - 0.486 0.287
P - 0.784 0.592
Han Chinese
Male 304 223 (73.4) 78 (25.7) 3 (1.0) 524 (86.2) 84 (13.8)
Female 320 249 (77.8) 67 (20.9) 4 (1.3) 565 (88.3) 75 (11.7)
c
2 - 2.001 1.233
P - 0.368 0.267
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normolipidemic (67.6%) and hyperlipidemic Japanese
s u b j e c t s( 6 3 . 3 % ) .T h e r ew a sa l s on od i f f e r e n c ei nt h e
allele frequency of the -77G > A variant in the ACAT-1
gene between normolipidemic (50.3%) and hyperlipi-
demic subjects (51.5%) [39]. In the population of central
and Southern Europe, however, the frequency of C allele
of rs1044925 in the ACAT-1 gene was very high (35.4%)
[40]. These results indicate that the prevalence of the C
allele variation of rs1044925 in the ACAT-1 gene may
have an ethnic specificity.
The association of rs1044925 polymorphism in the
ACAT-1 gene and plasma or serum lipid profiles is not
well documented. In a previous study in Japanese popula-
tion, Ohta et al. [39] reported that the R526G variant in
the ACAT-1 gene did not affect plasma lipid concentra-
tions in subjects studied. However, among hyperlipidemic
subjects, plasma HDL-C and ApoAI concentrations in
subjects with -77G > A variant in the ACAT-1 gene were
significantly higher than those in subjects without variant.
In another recent study in Han Chinese population, Li et
al. [38] found that control subjects with AA genotype had
a higher serum mean concentrations of LDL-C and non-
HDL-C when compared with those of C allele carriers
(AC and CC genotype carriers), whereas hypertriglyceride-
mia subjects with AA genotype had a higher HDL-C level
compared with those of C allele carriers. In the present
study, we showed that the levels of TC, LDL-C and ApoB
in Bai Ku Yao but not in Han were significant differences
between the AA and AC/CC genotypes in females but not
in males. The C allele carriers had lower serum TC, LDL-
C and ApoB levels as compared with the C allele noncar-
riers. The levels of TC, LDL-C and ApoB in Bai Ku Yao
but not in Han were also correlated with genotypes in
Table 3 The genotypes of rs1044925 polymorphism in the ACAT-1 gene and serum lipid levels between Bai Ku Yao
and Han Chinese
Genotype n TC
(mmol/L)
TG
(mmol/L)
HDL-C
(mmol/L)
LDL-C
(mmol/L)
ApoAI
(g/L)
ApoB
(g/L)
ApoAI/
ApoB
Bai Ku Yao
AA 396 4.36 ± 0.85 1.02(0.65) 1.67 ± 0.40 2.58 ± 0.70 1.32 ± 0.32 0.85 ± 0.22 1.67 ± 0.71
AC/CC 230 4.29 ± 0.90 0.96(0.66) 1.64 ± 0.41 2.55 ± 0.75 1.29 ± 0.31 0.84 ± 0.22 1.65 ± 0.73
F - 1.008 0.623 0.811 0.288 1.732 0.871 0.037
P - 0.316 0.534 0.368 0.591 0.189 0.351 0.847
Male
AA 191 4.35 ± 0.89 1.16(0.87) 1.72 ± 0.46 2.47 ± 0.72 1.39 ± 0.38 0.82 ± 0.21 1.86 ± 0.87
AC/CC 114 4.38 ± 1.02 1.02(0.74) 1.65 ± 0.46 2.57 ± 0.91 1.32 ± 0.35 0.85 ± 0.25 1.73 ± 0.92
F - 0.087 0.297 1.728 1.176 2.781 1.100 1.688
P - 0.768 0.766 0.190 0.279 0.096 0.295 0.195
Female
AA 205 4.39 ± 0.81 0.94(0.54) 1.64 ± 0.34 2.68 ± 0.66 1.26 ± 0.25 0.89 ± 0.23 1.50 ± 0.45
AC/CC 116 4.19 ± 0.75 0.92(0.54) 1.62 ± 0.34 2.52 ± 0.56 1.24 ± 0.24 0.83 ± 0.19 1.56 ± 0.47
F - 4.769 0.748 0.108 4.888 0.303 4.866 1.511
P - 0.030 0.454 0.743 0.028 0.583 0.028 0.220
Han Chinese
AA 472 4.73 ± 1.03 1.01(0.70) 1.89 ± 0.49 2.64 ± 0.78 1.41 ± 0.27 0.89 ± 0.23 1.69 ± 0.60
AC/CC 152 4.75 ± 1.00 1.00(0.64) 1.90 ± 0.52 2.60 ± 0.74 1.42 ± 0.29 0.89 ± 0.22 1.67 ± 0.50
F - 0.041 0.307 0.100 0.263 0.164 0.005 0.084
P - 0.839 0.759 0.751 0.608 0.685 0.946 0.772
Male
AA 223 4.64 ± 1.05 1.04(0.75) 1.81 ± 0.48 2.59 ± 0.79 1.38 ± 0.28 0.88 ± 0.24 1.69 ± 0.69
AC/CC 81 4.69 ± 1.10 0.98(0.75) 1.84 ± 0.62 2.54 ± 0.81 1.39 ± 0.33 0.88 ± 0.22 1.64 ± 0.47
F - 0.163 0.872 0.239 0.225 0.128 0.006 0.418
P - 0.687 0.383 0.625 0.636 0.721 0.94 0.518
Female
AA 249 4.81 ± 1.00 0.97(0.65) 1.96 ± 0.49 2.68 ± 0.78 1.45 ± 0.26 0.90 ± 0.21 1.69 ± 0.50
AC/CC 71 4.83 ± 0.87 1.07(0.58) 1.95 ± 0.39 2.69 ± 0.65 1.46 ± 0.24 0.91 ± 0.22 1.70 ± 0.53
F - 0.031 0.344 0.007 0.007 0.017 0.060 0.016
P - 0.861 0.731 0.935 0.932 0.896 0.806 0.898
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B.
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Page 7 of 13Table 4 Correlative factors for serum lipid parameters between Bai Ku Yao and Han Chinese
Lipid parameter Relative factor Unstandardized coefficient Std. error Standardized coefficient tP
Bai plus Han
TC Body mass index 0.070 0.009 0.204 7.493 0.000
Ethnic group 0.363 0.051 0.188 7.148 0.000
Age 0.010 0.002 0.160 5.953 0.000
Diastolic blood pressure 0.010 0.003 0.109 3.940 0.000
TG Body mass index 0.070 0.012 0.165 5.742 0.000
Alcohol consumption 0.185 0.074 0.076 2.478 0.013
Sex -0.247 0.074 -0.103 -3.355 0.001
Diastolic blood pressure 0.008 0.003 0.066 2.286 0.022
HDL-C Age 0.005 0.001 0.168 6.163 0.000
Alcohol consumption 0.207 0.028 0.219 7.358 0.000
Sex 0.127 0.028 0.135 4.566 0.000
Body mass index -0.015 0.005 -0.092 -3.334 0.001
Diastolic blood pressure 0.003 0.001 0.057 2.024 0.043
Ethnic group 0.247 0.025 0.264 9.979 0.000
LDL-C Body mass index 0.059 0.007 0.224 8.004 0.000
Age 0.007 0.001 0.143 5.136 0.000
Alcohol consumption -0.177 0.042 -0.117 -4.250 0.000
Diastolic blood pressure 0.005 0.002 0.063 2.187 0.029
ApoAI Age 0.004 0.001 0.194 7.110 0.000
Alcohol consumption 0.143 0.018 0.233 7.849 0.000
Ethnic group 0.120 0.016 0.198 7.479 0.000
Diastolic blood pressure 0.002 0.001 0.069 2.519 0.012
Sex -0.037 0.018 -0.061 -2.068 0.039
ApoB Body mass index 0.018 0.002 0.223 8.019 0.000
Age 0.002 0.000 0.141 5.120 0.000
Diastolic blood pressure 0.002 0.001 0.100 3.487 0.001
Sex 0.032 0.012 0.071 2.613 0.009
Ethnic group 0.034 0.012 0.076 2.852 0.004
ApoAI/ApoB Alcohol consumption 0.227 0.037 0.172 6.219 0.000
Body mass index -0.034 0.006 -0.148 -5.360 0.000
Bai Ku Yao
TC Body mass index 0.087 0.014 0.239 6.190 0.000
Age 0.008 0.002 0.138 3.570 0.000
TG Alcohol consumption 0.218 0.065 0.155 3.366 0.001
Body mass index 0.055 0.016 0.137 3.486 0.001
Sex -0.229 0.089 -0.119 -2.581 0.010
HDL-C Alcohol consumption 0.117 0.023 0.198 5.099 0.000
Age 0.004 0.001 0.152 3.905 0.000
LDL-C Body mass index 0.077 0.012 0.255 6.587 0.000
Age 0.006 0.002 0.124 3.215 0.001
Alcohol consumption -0.093 0.041 -0.089 -2.278 0.023
ApoAI Alcohol consumption 0.140 0.018 0.300 7.951 0.000
Age 0.003 0.001 0.151 3.999 0.000
ApoB Body mass index 0.023 0.004 0.249 6.458 0.000
Age 0.002 0.001 0.117 3.036 0.002
ApoAI/ApoB Alcohol consumption 0.278 0.040 0.266 6.916 0.000
Body mass index -0.048 0.012 -0.159 -4.127 0.000
Han Chinese
TC Age 0.013 0.002 0.193 5.015 0.000
Body mass index 0.055 0.012 0.173 4.410 0.000
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Page 8 of 13Table 4: Correlative factors for serum lipid parameters between Bai Ku Yao and Han Chinese (Continued)
Diastolic blood pressure 0.017 0.004 0.173 4.285 0.000
Sex 0.161 0.077 0.079 2.098 0.036
TG Body mass index 0.071 0.018 0.164 4.005 0.000
Alcohol consumption 0.309 0.090 0.135 3.448 0.001
Diastolic blood pressure 0.011 0.005 0.084 2.033 0.042
HDL-C Age 0.006 0.001 0.198 5.022 0.000
Alcohol consumption 0.170 0.033 0.209 5.129 0.000
Sex 0.212 0.040 0.213 5.258 0.000
Body mass index -0.020 0.006 -0.126 -3.172 0.002
Diastolic blood pressure 0.005 0.002 0.099 2.429 0.015
LDL-C Body mass index 0.053 0.009 0.221 5.726 0.000
Age 0.009 0.002 0.190 4.858 0.000
Alcohol consumption -0.135 0.049 -0.107 -2.760 0.006
ApoAI Age 0.004 0.001 0.251 6.467 0.000
Alcohol consumption 0.086 0.018 0.189 4.721 0.000
Sex 0.106 0.022 0.191 4.818 0.000
Diastolic blood pressure 0.003 0.001 0.103 2.677 0.008
ApoB Body mass index 0.015 0.003 0.218 5.547 0.000
Age 0.003 0.001 0.195 5.069 0.000
Diastolic blood pressure 0.003 0.001 0.119 2.979 0.003
ApoAI/ApoB Body mass index -0.027 0.007 -0.152 -3.847 0.000
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B
Table 5 Correlative factors for serum lipid parameters between males and females in both ethnic groups
Lipid parameter Relative factor Unstandardized coefficient Std. error Standardized coefficient tP
Bai Ku Yao
Male
TC Body mass index 0.138 0.023 0.323 6.017 0.000
Age 0.009 0.003 0.147 2.739 0.007
TG Body mass index 0.100 0.031 0.185 3.256 0.001
Alcohol consumption 0.308 0.153 0.115 2.015 0.045
HDL-C Age 0.007 0.002 0.229 4.185 0.000
Alcohol consumption 0.249 0.058 0.237 4.248 0.000
Body mass index -0.025 0.012 -0.118 -2.158 0.032
LDL-C Body mass index 0.119 0.020 0.327 6.023 0.000
ApoAI Alcohol consumption 0.226 0.046 0.271 4.969 0.000
Age 0.005 0.001 0.203 3.716 0.000
Apo B Body mass index 0.032 0.006 0.312 5.709 0.000
ApoAI/ApoB Alcohol consumption 0.484 0.114 0.239 4.252 0.000
Body mass index -0.075 0.023 -0.184 -3.264 0.001
Female
TC Body mass index 0.044 0.017 0.139 2.511 0.013
Genotype -0.213 0.091 -0.129 -2.333 0.020
TG Body mass index 0.031 0.014 0.124 2.241 0.026
LDL-C Systolic blood pressure 0.005 0.002 0.128 2.326 0.021
Body mass index 0.032 0.014 0.126 2.290 0.023
Genotype -0.151 0.072 -0.115 -2.086 0.038
ApoAI Alcohol consumption 0.070 0.034 0.114 2.061 0.040
Age 0.002 0.001 0.112 2.030 0.043
ApoB Body mass index 0.013 0.005 0.152 2.777 0.006
Systolic blood pressure 0.002 0.001 0.136 2.477 0.014
Wu et al. Lipids in Health and Disease 2010, 9:139
http://www.lipidworld.com/content/9/1/139
Page 9 of 13females but not in males. These results suggest that the
polymorphism of rs1044925 in the ACAT-1 gene is mainly
associated with female serum TC, LDL-C and ApoB levels
in the Bai Ku Yao population. The reason for this discre-
pancy between the two ethnic groups is unclear.
Several environmental factors were also found to
affect serum lipid levels in this study. Serum lipid para-
meters were correlated with age, sex, alcohol consump-
t i o n ,B M I ,a n db l o o dp r e s s u r e .T h e s ed a t as u g g e s tt h a t
the environmental factors also play an important role in
determining serum lipid levels in our populations
[13,14]. The diet and lifestyle were different between the
two ethnic groups. Corn was the staple food and rice,
soy, buckwheat, sweet potato, and pumpkin products
were the subsidiary foods in Bai Ku Yao. Approxi-
mately 90% of the beverages were corn wine and rum.
The alcohol content is about 15% (v/v). They are also
accustomed to drink hempseed soup and eat hempseed
products. In contrast, rice was the staple food and corn,
broomcorn, potato, and taro products were the subsidi-
ary foods in Han. About 90% of the beverage was rice
wine. The content of alcohol is about 30% (v/v). The
staple and subsidiary foods are more favorable for
serum lipid profiles in Bai Ku Yao than in Han. Corn
contains abundant dietary fiber and plant protein [46].
Consumption of dietary fiber, specifically the soluble
Table 5: Correlative factors for serum lipid parameters between males and females in both ethnic groups (Continued)
Genotype -0.052 0.025 -0.117 -2.128 0.034
ApoAI/ApoB Diastolic blood pressure -0.007 0.003 -0.132 -2.381 0.018
Han Chinese
Male
TC Body mass index 0.065 0.018 0.206 3.552 0.000
Age 0.012 0.004 0.179 3.229 0.001
Diastolic blood pressure 0.013 0.006 0.138 2.347 0.020
TG Body mass index 0.138 0.028 0.271 4.892 0.000
HDL-C Alcohol consumption 0.308 0.055 0.297 5.587 0.000
Age 0.009 0.002 0.267 4.962 0.000
Body mass index -0.022 0.008 -0.145 -2.771 0.006
LDL-C Body mass index 0.047 0.013 0.204 3.612 0.000
Age 0.006 0.003 0.132 2.341 0.020
ApoAI Alcohol consumption 0.178 0.031 0.303 5.788 0.000
Age 0.005 0.001 0.268 5.066 0.000
Diastolic blood pressure 0.003 0.001 0.111 2.133 0.034
ApoB Body mass index 0.018 0.004 0.262 4.797 0.000
Age 0.003 0.001 0.199 3.645 0.000
ApoAI/ApoB Alcohol consumption 0.183 0.073 0.143 2.515 0.012
Body mass index -0.035 0.011 -0.183 -3.123 0.002
Systolic blood pressure 0.005 0.002 0.119 2.011 0.045
Female
TC Diastolic blood pressure 0.020 0.005 0.205 3.715 0.000
Age 0.013 0.003 0.208 3.863 0.000
Body mass index 0.045 0.017 0.143 2.662 0.008
TG Diastolic blood pressure 0.016 0.005 0.160 2.884 0.004
HDL-C Age 0.005 0.002 0.162 2.921 0.004
LDL-C Body mass index 0.053 0.013 0.213 3.961 0.000
Age 0.010 0.003 0.208 3.819 0.000
Alcohol consumption -0.319 0.095 -0.176 -3.346 0.001
Diastolic blood pressure 0.009 0.004 0.124 2.242 0.026
ApoAI Age 0.004 0.001 0.249 4.588 0.000
ApoB Diastolic blood pressure 0.004 0.001 0.190 3.467 0.001
Body mass index 0.014 0.004 0.196 3.654 0.000
Age 0.003 0.001 0.191 3.559 0.000
ApoAI/ApoB Body mass index -0.028 0.009 -0.170 -3.076 0.002
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B
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Page 10 of 13type, such as pectins and guar gum can decrease serum
TC levels [47,48]. Corn fiber supplementation in men
with hypercholesterolemia resulted in an additional low-
ering of serum TC, TG, and VLDL-C concentrations.
Serum LDL-C and HDL-C concentrations were not sig-
nificantly altered by corn fiber or wheat fiber supple-
mentation [48]. Plant protein might promote the
transportation and excretion of free cholesterol. Dietary
soy protein has well-documented beneficial effects on
serum lipid concentrations [49,50]. Buckwheat protein
product has a potent hypocholesterolemic activity
[51,52]. Low to high buckwheat seed and sprout meal
can reduce serum TC levels. The high seed and sprout
meals can also lower serum TG levels. The levels of
serum LDL-C were significantly suppressed by all buck-
wheat meals. Serum HDL-C levels were increased, how-
ever, insignificantly. Nutraceutically more meaningful is
that both LDL-C/HDL-C and TC/HDL-C ratios were
significantly lowered [52]. Ingestion of 4 g/day caiapo
(the extract of the white-skinned sweet potato Ipomoea
batatas) for 6 weeks has been found to reduce plasma
TC, LDL-C [53] and TG levels [54] in type 2 diabetic
patients previously treated by diet alone. Adaramoye et
al. [55] reported that supplemented diets containing 3%
and 6% telfairia occidentalis (fluted pumpkin) in rats
decreased plasma and postmitochondrial supernatant
fraction (PMF) cholesterol levels by 20% and 30% and by
30% and 45%, respectively; decreased the cholesterol-
induced increase in plasma and PMF LDL-C levels by
24% and 48% and by 28% and 52%, respectively; and
decreased plasma and PMF lipid peroxidation by 24%
and 20% and by 42% and 21%, respectively. Dietary
hempseed is a rich source of polyunsaturated fatty acids
(PUFAs). Hempseed-supplemented diet in animals
displayed elevated plasma levels of PUFAs and a promi-
nent enhancement in gamma-linolenic acid levels. When
hempseed is added to a cholesterol-enriched diet, choles-
terol-induced platelet aggregation returns to control
levels [56,57]. This normalization may be partly due to
increased levels of plasma gamma-linolenic acid [56]. In
addition, several experimental and clinical studies have
demonstrated that dietary hempseed or hempseed oil can
decrease TC, TG and LDL-C levels [58-60], inhibit lipid
peroxidation [61], and reduce atherogenic index [62].
Conclusion
The present study shows that the frequency of C allele of
rs1044925 in the ACAT-1 gene was higher in Bai Ku Yao
than in Han Chinese. But only the levels of TC, LDL-C
a n dA p o Bi nB a iK uY a ob u tn o ti nH a nw e r ed i f f e r e n t
between the AA and AC/CC genotypes in females but
not in males. The C allele carriers had lower serum TC,
LDL-C and ApoB levels than the C allele noncarriers.
The levels of TC, LDL-C and ApoB in Bai Ku Yao but
not in Han were also correlated with genotypes in
females but not in males. These results suggest that the
polymorphism of rs1044925 in the ACAT-1 gene is
mainly associated with female serum TC, LDL-C and
ApoB levels in the Bai Ku Yao population.
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